Michael P. Cooreman
Chief Tech/Sci/R&D Officer bij INVENTIVA
Profiel
Presently, Michael P.
Cooreman is Chief Medical Officer for Inventiva SA.
In his past career he was Chief Medical Officer at ImmusanT, Inc. and Vice President-Science & Medicine at Ferring Pharmaceuticals, Inc.
Dr. Cooreman received a doctorate from Université Catholique de Louvain and a doctorate from Heinrich-Heine-Universität Düsseldorf.
Actieve functies van Michael P. Cooreman
Bedrijven | Functie | Begin |
---|---|---|
INVENTIVA | Chief Tech/Sci/R&D Officer | 01-11-2020 |
Eerdere bekende functies van Michael P. Cooreman
Bedrijven | Functie | Einde |
---|---|---|
Ferring Pharmaceuticals, Inc.
Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals, Inc. develops and markets fertility and endocrinology products. Its products include Bravelle, Repronex, Novarel, Acthrel and Desmopressin Acetate. The company's products are used in treatment of osteoarthritis, prostate cancer, and other infertility related diseases. Ferring Pharmaceuticals was founded in 1951 and is headquartered in Parsippany, NJ. | Corporate Officer/Principal | 01-01-2020 |
ImmusanT, Inc.
ImmusanT, Inc. Medical SpecialtiesHealth Technology ImmusanT, Inc. develops a new class of therapeutic vaccines to change the lives of people living with autoimmune diseases. Its Epitope-Specific Immuno-Therapy platform provides a precision medicine approach to restoring immune tolerance across a range of diseases, including celiac disease and type 1 diabetes. The firm’s product Nexvax2, protects celiac disease patients against the debilitating effects of gluten. The company was by Leslie J. Williams and Robert P. Anderson founded in December 2010 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 01-01-2017 |
Opleiding van Michael P. Cooreman
Heinrich-Heine-Universität Düsseldorf | Doctorate Degree |
Université Catholique de Louvain | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
INVENTIVA | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Ferring Pharmaceuticals, Inc.
Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals, Inc. develops and markets fertility and endocrinology products. Its products include Bravelle, Repronex, Novarel, Acthrel and Desmopressin Acetate. The company's products are used in treatment of osteoarthritis, prostate cancer, and other infertility related diseases. Ferring Pharmaceuticals was founded in 1951 and is headquartered in Parsippany, NJ. | Health Technology |
ImmusanT, Inc.
ImmusanT, Inc. Medical SpecialtiesHealth Technology ImmusanT, Inc. develops a new class of therapeutic vaccines to change the lives of people living with autoimmune diseases. Its Epitope-Specific Immuno-Therapy platform provides a precision medicine approach to restoring immune tolerance across a range of diseases, including celiac disease and type 1 diabetes. The firm’s product Nexvax2, protects celiac disease patients against the debilitating effects of gluten. The company was by Leslie J. Williams and Robert P. Anderson founded in December 2010 and is headquartered in Cambridge, MA. | Health Technology |